<DOC>
	<DOCNO>NCT00163293</DOCNO>
	<brief_summary>The aim study compare efficacy ciclesonide respect reduction number asthma exacerbation child mild persistent asthma . Treatment medication administer follow : ciclesonide inhale daily , use one two dose level versus placebo together corticosteroid use intermittent treatment . The study duration consist baseline period ( 3 4 week ) treatment period ( 12 month ) . The study provide data safety tolerability ciclesonide .</brief_summary>
	<brief_title>Efficacy Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used Treatment Mild Asthma Children ( 4 11 ) ( BY9010/CA-101 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main Outpatients Symptoms consistent diagnosis asthma least 12 month FEV1 least 80 % predicted Patients history reversible airway obstruction Good health exception asthma Main History lifethreatening asthma A hospitalization asthma within last 3 month , two hospitalization asthma within last year Concomitant severe disease disease contraindication use inhaled steroid Patients suffer relevant lung disease cause alternate impairment lung function ( e.g . chronic bronchitis emphysema ) Prematurely born child ( &lt; 36 week gestation ) Smokers Pregnancy ( intention become pregnant course trial ) , breast feeding lack safe contraception female childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Exacerbation</keyword>
</DOC>